Evidence map›Paper›PMID 28453717›Full record

ArticleHealth policy and planning2017

Reaching the global target to reduce stunting: an investment framework.

Meera Shekar, Jakub Kakietek, Mary R D'Alimonte, Hilary E Rogers, Julia Dayton Eberwein, Jon Kweku Akuoku, Audrey Pereira, Shan Soe-Lin, Robert Hecht

Abstract read
In one paragraph

Article in Health policy and planning, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Meera ShekarHealth, Nutrition and Population Global Practice, World Bank, 1818?H Street NW, Washington, DC 20433, USA.
Jakub KakietekHealth, Nutrition and Population Global Practice, World Bank, 1818?H Street NW, Washington, DC 20433, USA.
Mary R D'AlimonteResults for Development, 1111 19th Street NW, Washington, DC 20036, USA.
Hilary E RogersResults for Development, 1111 19th Street NW, Washington, DC 20036, USA.
Julia Dayton EberweinHealth, Nutrition and Population Global Practice, World Bank, 1818?H Street NW, Washington, DC 20433, USA.
Jon Kweku AkuokuHealth, Nutrition and Population Global Practice, World Bank, 1818?H Street NW, Washington, DC 20433, USA.
Audrey PereiraHealth, Nutrition and Population Global Practice, World Bank, 1818?H Street NW, Washington, DC 20433, USA.
Shan Soe-LinResults for Development, 1111 19th Street NW, Washington, DC 20036, USA.
Robert HechtResults for Development, 1111 19th Street NW, Washington, DC 20036, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Childhood stunting, being short for one's age, has life-long consequences for health, human capital and economic growth. Being stunted in early childhood is associated with slower cognitive development, reduced schooling attainment and adult incomes decreased by 5-53%. The World Health Assembly has endorsed global nutrition targets including one to reduce the number of stunted children under five by 40% by 2025. The target has been included in the Sustainable Development Goals (SDG target 2.2). This paper estimates the cost of achieving this target and develops scenarios for generating the necessary financing. We focus on a key intervention package for stunting (KIPS) with strong evidence of effectiveness. Annual scale-up costs for the period of 2016-25 were estimated for a sample of 37 high burden countries and extrapolated to all low and middle income countries. The Lives Saved Tool was used to model the impact of the scale-up on stunting prevalence. We analysed data on KIPS budget allocations and expenditure by governments, donors and households to derive a global baseline financing estimate. We modelled two financing scenarios, a 'business as usual', which extends the current trends in domestic and international financing for nutrition through 2025, and another that proposes increases in financing from all sources under a set of burden-sharing rules. The 10-year financial need to scale up KIPS is US$49.5 billion. Under 'business as usual', this financial need is not met and the global stunting target is not reached. To reach the target, current financing will have to increase from US$2.6 billion to US$7.4 billion a year on average. Reaching the stunting target is feasible but will require large coordinated investments in KIPS and a supportive enabling environment. The example of HIV scale-up over 2001-11 is instructive in identifying the factors that could drive such a global response to childhood stunting.

Indexed as

Child Nutrition DisordersChild, PreschoolFinancial SupportFinancing, GovernmentFood AssistanceGlobal HealthGrowth DisordersHumansInfantInternational CooperationNutritional StatusNutrition PolicyChild healthcosthealth financingmalnutrition

Identifiers

PMID28453717
PMCPMC5406759

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.